Using imaging to improve lung cancer diagnosis
Macro-vasculature: A Novel Image Biomarker of Lung Cance
This study is working on a new way to look at lung nodules from CT scans to help tell the difference between harmless and cancerous ones, so patients can avoid unnecessary worry and extra tests.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10770368 on NIH RePORTER |
What this research studies
This research focuses on developing a new imaging biomarker that can help distinguish between benign and malignant lung nodules detected during screening. By utilizing advanced imaging techniques, the study aims to reduce the number of false-positive results that often lead to unnecessary follow-up procedures and anxiety for patients. The researchers will validate this new biomarker across various CT scan protocols and integrate it with clinical data to enhance diagnostic accuracy. This approach seeks to improve early detection of lung cancer, ultimately aiming to save lives.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have been identified with indeterminate lung nodules during screening or those at high risk for lung cancer.
Not a fit: Patients who do not have lung nodules or are not at risk for lung cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate lung cancer screenings, reducing unnecessary procedures and improving early diagnosis.
How similar studies have performed: Previous research has shown promise in using imaging biomarkers for cancer diagnosis, indicating that this approach could be effective.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Pu, Jiantao — University of Pittsburgh at Pittsburgh
- Study coordinator: Pu, Jiantao
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.